Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

3H5B

Crystal structure of wild type HIV-1 protease with novel P1'-ligand GRL-02031

Summary for 3H5B
Entry DOI10.2210/pdb3h5b/pdb
Related2HB3 2IEN 2Z4O 3DJK 3DK1
DescriptorHIV-1 protease, SODIUM ION, CHLORIDE ION, ... (6 entities in total)
Functional Keywordshiv-1, wild type protease, protease inhibitor, p1'-ligand, aids, hydrolase
Biological sourceHuman immunodeficiency virus type 1 (BRU ISOLATE) (HIV-1)
Cellular locationGag-Pol polyprotein: Host cell membrane ; Lipid-anchor. Matrix protein p17: Virion membrane; Lipid- anchor . Capsid protein p24: Virion . Nucleocapsid protein p7: Virion . Reverse transcriptase/ribonuclease H: Virion . Integrase: Virion : P03367
Total number of polymer chains2
Total formula weight22269.06
Authors
Tie, Y.,Wang, Y.F.,Weber, I.T. (deposition date: 2009-04-21, release date: 2009-06-16, Last modification date: 2023-09-06)
Primary citationGhosh, A.K.,Leshchenko-Yashchuk, S.,Anderson, D.D.,Baldridge, A.,Noetzel, M.,Miller, H.B.,Tie, Y.,Wang, Y.F.,Koh, Y.,Weber, I.T.,Mitsuya, H.
Design of HIV-1 protease inhibitors with pyrrolidinones and oxazolidinones as novel P1'-ligands to enhance backbone-binding interactions with protease: synthesis, biological evaluation, and protein-ligand X-ray studies.
J.Med.Chem., 52:3902-3914, 2009
Cited by
PubMed Abstract: Structure-based design, synthesis, and biological evaluation of a series of novel HIV-1 protease inhibitors are described. In an effort to enhance interactions with protease backbone atoms, we have incorporated stereochemically defined methyl-2-pyrrolidinone and methyl oxazolidinone as the P1'-ligands. These ligands are designed to interact with Gly-27' carbonyl and Arg-8 side chain in the S1'-subsite of the HIV protease. We have investigated the potential of these ligands in combination with our previously developed bis-tetrahydrofuran (bis-THF) and cyclopentanyltetrahydrofuran (Cp-THF) as the P2-ligands. Inhibitor 19b with a (R)-aminomethyl-2-pyrrolidinone and a Cp-THF was shown to be the most potent compound. This inhibitor maintained near full potency against multi-PI-resistant clinical HIV-1 variants. A high resolution protein-ligand X-ray crystal structure of 19b-bound HIV-1 protease revealed that the P1'-pyrrolidinone heterocycle and the P2-Cp-ligand are involved in several critical interactions with the backbone atoms in the S1' and S2 subsites of HIV-1 protease.
PubMed: 19473017
DOI: 10.1021/jm900303m
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.29 Å)
Structure validation

246704

PDB entries from 2025-12-24

PDB statisticsPDBj update infoContact PDBjnumon